Danasupra Erapacific Tbk. vs Merck Tbk. — how do they compare? Danasupra Erapacific Tbk. trades at Rp105 (market cap 72.85B, 10.82M 24h volume), while Merck Tbk. trades at Rp3,840 (market cap 1.7T, 37.6K 24h volume). The key difference: Merck Tbk. is far larger — about 23.3× Danasupra Erapacific Tbk.'s market cap, and Danasupra Erapacific Tbk. is more actively traded (10.82M versus 37.6K). Which is the better fit depends on your goals.
| DEFI | MERK | |
|---|---|---|
Market Cap | 72.85B | 1.7T |
Volume | 10.82M | 37.6K |
Lot | 108.22K | 376 |
Turnover | 1.14B | 144.47M |
Average Price | 105.37 | 3,842.23 |
Value | 1.14B | 144.47M |
Indicative Equilibrium Price | 105 | 3,840 |
Indicative Equilibrium Volume | 5.42K | 7 |
Trailing returns across standard periods
Latest headlines on both assets
Danasupra Erapacific Tbk PT. (The "Company") was established by notarial act Elliza, SH. no 65 dated 11 November 1994. Articles of the company has been approved by the Ministry of Justice of the Republic of Indonesia in its Decision Letter. C2-1.101.HT.01.01.Th.95 dated January 25, 1995. Based on the Notary Act Refizal, SH. 12, dated January 18, 2000 the company made changes to the status of the company closed to open company, authorized capital, change in nominal value of shares and public offering through the stock market. Articles of Association was approved by the Minister of Law and Legislation of the Republic of Indonesia in its Decision Letter. C-1248.HT.01.04.Th.2000 dated February 3, 2000.Accordance with Article 3 Articles of Association, the scope of its business is run financing activities which include consumer finance, factoring and leasing.
Read more on DEFI →PT Merck Tbk (the Company) is domiciled in Indonesia and located at Jl. TB Simatupang No. 8, Pasar Rebo, East Jakarta, was established in framework of Law No. 1 of 1967 and Law No. 11 of 1970 on foreign capital investment by deed of notary public Eliza Pondaag, SH dated 14 October 1970 No. 29. PT Merck Indonesia is a member of the Merck International Group. The company produces pharmaceutical products with production facility in East Jakarta. It commenced its operation in 1974 in manufacturing medical products, such as Songobian and Neurobion.
Read more on MERK →